About Galen Medical Group
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Galen Medical Group
During the past decade, Galen Medical Group conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
1993-04-01
Completed
1,929
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
1998-10-01
2004-10-01
Completed
1,691
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
1999-07-16
2012-03-01
Terminated
59
Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
2000-01-01
2010-03-01
Terminated
589
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
2000-08-01
2012-07-01
Completed
432
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Galen Medical Group
According to Clinical.Site data, the most researched conditions in "Galen Medical Group" are
"Ulcerative Colitis" (2 trials), "Heartburn" (1 trials), "Non-Erosive Gastro-Esophageal Reflux Disease" (1 trials) and "Primary Sclerosing Cholangitis" (1 trials). Many other conditions were trialed in "Galen Medical Group" in a lesser frequency.
Clinical Trials Intervention Types at Galen Medical Group
Most popular intervention types in "Galen Medical Group" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Mirikizumab" (1 trials), "Mirikizumab IV" (1 trials), "Mirikizumab SC" (1 trials) and "Placebo SC" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Galen Medical Group
The vast majority of trials in "Galen Medical Group" are
4 trials for "All" genders.
Clinical Trials Status at Galen Medical Group
Currently, there are NaN active trials in "Galen Medical Group".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Galen Medical Group,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Galen Medical Group, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".